Skip to main content
Manish Kohli
( out of 43 reviews )

Manish Kohli, MD

  • Dr. Manish Kohli graduated in 1990 from the University of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the University of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the University of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined University of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-University of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the University of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on “convergence sciences” which combines population based trials with precision medicine concepts.

    Patient Rating

    4.9 /5
    ( out of 43 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 25, 2023
    HUNTSMAN CANCER CENTER

    We have great faith and confidence in Dr. Kohli. I know he has my best interest in hand. He's wonderful.

    August 12, 2023
    HUNTSMAN CANCER CENTER

    Personable & knowledgeable & current on best options!

    July 22, 2023
    HUNTSMAN CANCER CENTER

    Has a very soft spoken, kind and caring manner. His way of explaining my condition was clear and understandable. My questions were answered clearly and completely.

    July 21, 2023
    HUNTSMAN CANCER CENTER

    Excellent rapport and professional demeanor; he is very thoughtful and attentive .

    May 20, 2023
    HUNTSMAN CANCER CENTER

    Belief in his evaluation and skill

    March 25, 2023
    HUNTSMAN CANCER CENTER

    An XCLNT (Excellent) Service (O_O) Highly Recommended (O)__(O) Doctor Manish Kohli, Jennifer and other Great employees are not only Professionals and knowledgeable but Friendly as well.

    February 04, 2023
    HUNTSMAN CANCER CENTER

    Dr.Kohli seems to realy seems to carte. He invites questions and explains the treatments.

    December 16, 2022
    HUNTSMAN CANCER CENTER

    Dr Kohls takes the time with interest in mind to ask questions and answer questions and he probs until you convince him that you understand !

    December 11, 2022
    HUNTSMAN CANCER CENTER

    He was very patient in explaining things. Often times more than once. He treated me as if I was the only patient he had. Taking his time with me.

  • Dr. Manish Kohli graduated in 1990 from the University of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the University of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the University of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined University of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-University of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the University of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on “convergence sciences” which combines population based trials with precision medicine concepts.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Occupational Therapy